Autologous cell therapy-mouth disorders - Isolagen
Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Isolagen
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gingivitis; Periodontal disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Gingivitis in USA
- 16 Jul 2016 No recent reports of development identified for phase-I development in Periodontal-disorders in USA
- 12 Mar 2004 Phase-I clinical trials in Gingivitis in USA (unspecified route)